Skip to main content
. Author manuscript; available in PMC: 2025 Oct 31.
Published in final edited form as: Am J Physiol Endocrinol Metab. 2025 Sep 12;329(5):E707–E718. doi: 10.1152/ajpendo.00084.2025

Figure 3. Micro computed tomography results on treated and control femoral heads.

Figure 3.

A-B. Representative cross sections of the femoral heads of rabbits treated with 0.6 μg/kg/day of ACTH1–24 for five weeks (A) or given saline only (B).

C-F. Computed tomography results of separate measurements (upper and low part of the femoral head) from each of five ACTH and five saline treated animals are shown.

C. ACTH1–24 increases trabecular bone volume, p = 0.026.

D. ACTH1–24 increases intersection surface, p = 0.0302.

E. ACTH1–24 increases trabecular number (trabeculae per distance), p = 0.0457.

F. ACTH1–24 decreases porosity relative to saline control, p = 0.029.